Arnon Rosenthal
Fortuna: 14 M $ al 31/05/2026
Fortuna: 14 M $ al 31/05/2026
Arnon Rosenthal was the founder of Annexon, Inc. (founded in 2011, titled: Chairman from 2014 to 2017), Rinat Neuroscience Corp.
(founded in 2001, titled: President, Director & Chief Scientific Officer from 2001 to 2006), and Alector, Inc. (founded in 2013, titled: Chief Executive Officer & Director since 2019).
Former job at Genentech, Inc. as Scientist from 1985 to 2001.
Education includes a doctorate from The Hebrew University of Jerusalem.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ALECTOR, INC. 5,67 % | 02/06/2026 | 6.297.581 ( 5,67 % ) | 14 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALECTOR, INC. | Fundador | 01/05/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
| ANNEXON, INC. | Director Ejecutivo | 01/12/2014 |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Fundador | 01/08/2006 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2001 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.